LYEL
Price
$0.47
Change
-$0.04 (-7.84%)
Updated
Apr 3 closing price
Capitalization
137.67M
39 days until earnings call
NTLA
Price
$6.89
Change
-$0.41 (-5.62%)
Updated
Apr 3 closing price
Capitalization
712.2M
27 days until earnings call
Ad is loading...

LYEL vs NTLA

Header iconLYEL vs NTLA Comparison
Open Charts LYEL vs NTLABanner chart's image
Lyell Immunopharma
Price$0.47
Change-$0.04 (-7.84%)
Volume$888.35K
Capitalization137.67M
Intellia Therapeutics
Price$6.89
Change-$0.41 (-5.62%)
Volume$3.89M
Capitalization712.2M
LYEL vs NTLA Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. NTLA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (LYEL: $0.47 vs. NTLA: $6.89)
Brand notoriety: LYEL and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 83% vs. NTLA: 114%
Market capitalization -- LYEL: $137.67M vs. NTLA: $712.2M
LYEL [@Biotechnology] is valued at $137.67M. NTLA’s [@Biotechnology] market capitalization is $712.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • LYEL’s TA Score: 5 bullish, 5 bearish.
  • NTLA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than NTLA.

Price Growth

LYEL (@Biotechnology) experienced а -21.45% price change this week, while NTLA (@Biotechnology) price change was -17.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

LYEL is expected to report earnings on May 13, 2025.

NTLA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($712M) has a higher market cap than LYEL($138M). LYEL YTD gains are higher at: -27.344 vs. NTLA (-40.909). LYEL has higher annual earnings (EBITDA): -200.64M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. LYEL (371M). LYEL has less debt than NTLA: LYEL (59M) vs NTLA (210M). NTLA has higher revenues than LYEL: NTLA (57.9M) vs LYEL (61K).
LYELNTLALYEL / NTLA
Capitalization138M712M19%
EBITDA-200.64M-523.98M38%
Gain YTD-27.344-40.90967%
P/E RatioN/AN/A-
Revenue61K57.9M0%
Total Cash371M602M62%
Total Debt59M210M28%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELNTLA
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 29 days ago
83%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AASOX15.10N/A
N/A
Alger Small Cap Growth I-2
PCAOX75.69N/A
N/A
Principal Capital Appreciation R3
AQGRX11.22N/A
N/A
AQR Global Equity R6
PAXLX11.99N/A
N/A
Impax Large Cap Fund Individual Investor
LYRVX12.40N/A
N/A
Lyrical International Value Equity A

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-8.37%
VCYT - LYEL
46%
Loosely correlated
-5.51%
PRME - LYEL
43%
Loosely correlated
-10.06%
CRBU - LYEL
43%
Loosely correlated
-8.83%
RCKT - LYEL
43%
Loosely correlated
-11.75%
NTLA - LYEL
41%
Loosely correlated
-5.62%
More